We do hope that you have found the articles published throughout the year in the American Journal of Cardiovascular Drugs to be interesting and informative. The editorial schedule for 2020 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.
We thank the authors who have contributed articles to the American Journal of Cardiovascular Drugs over the course of 2019. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal's content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for the American Journal of Cardiovascular Drugs in the last 12 months:
